Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 7
2011 10
2012 16
2013 19
2014 12
2015 7
2016 6
2017 6
2018 9
2019 15
2020 19
2021 19
2022 10
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, Giglhuber K, Zephir H, Kümpfel T, Berger R, Röther J, Häußler V, Stellmann JP, Whittam D, Jacob A, Kraemer M, Gueguen A, Deschamps R, Bayas A, Hümmert MW, Trebst C, Haarmann A, Jarius S, Wildemann B, Grothe M, Siebert N, Ruprecht K, Paul F, Collongues N, Marignier R, Levy M, Karenfort M, Deppe M, Albrecht P, Hellwig K, Gold R, Hartung HP, Meuth SG, Kleiter I, Aktas O; Neuromyelitis Optica Study Group (NEMOS). Ringelstein M, et al. Among authors: collongues n. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 16;9(1):e1100. doi: 10.1212/NXI.0000000000001100. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34785575 Free PMC article.
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.
Giovannelli J, Ciron J, Cohen M, Kim HJ, Kim SH, Stellmann JP, Kleiter I, McCreary M, Greenberg BM, Deschamps R, Audoin B, Maillart E, Papeix C, Collongues N, Bourre B, Laplaud D, Ayrignac X, Durand-Dubief F, Ruet A, Vukusic S, Marignier R, Dauchet L, Zephir H; NEMOS (Neuromyelitis Optica Study Group in Germany), NOMADMUS (Neuromyelitis Optica study Group in France), OFSEP (Observatoire Français de la Sclérose en Plaques) investigators. Giovannelli J, et al. Among authors: collongues n. Ann Clin Transl Neurol. 2021 Oct;8(10):2025-2037. doi: 10.1002/acn3.51451. Epub 2021 Sep 10. Ann Clin Transl Neurol. 2021. PMID: 34505407 Free PMC article.
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
Demuth S, Guillaume M, Bourre B, Ciron J, Zephir H, Sirejacob Y, Kerbrat A, Lebrun-Frenay C, Papeix C, Michel L, Laplaud D, Vukusic S, Maillart E, Cohen M, Audoin B, Marignier R, Collongues N; NOMADMUS Study Group. Demuth S, et al. Among authors: collongues n. J Neuroinflammation. 2022 Mar 2;19(1):62. doi: 10.1186/s12974-022-02420-2. J Neuroinflammation. 2022. PMID: 35236386 Free PMC article.
[Love and neurology].
Collongues N, Cretin B, de Seze J, Blanc F. Collongues N, et al. Rev Neurol (Paris). 2011 Feb;167(2):105-13. doi: 10.1016/j.neurol.2010.03.023. Epub 2010 May 13. Rev Neurol (Paris). 2011. PMID: 20466399 Review. French.
[Sepsis associated encephalopathy].
Cretin B, Collongues N, Philippi N, Blanc F. Cretin B, et al. Among authors: collongues n. Rev Neurol (Paris). 2011 Mar;167(3):195-204. doi: 10.1016/j.neurol.2010.07.019. Rev Neurol (Paris). 2011. PMID: 20888023 Review. French.
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S. Gallais F, et al. Among authors: collongues n. EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27. EBioMedicine. 2021. PMID: 34455390 Free PMC article.
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Cobo-Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E, Papeix C, Audoin B, Lépine AF, Maurey H, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Meyer P, Thouvenot E, Bourre B, Montcuquet A, Cohen M, Horello P, Tintoré M, De Seze J, Vukusic S, Deiva K, Marignier R; NOMADMUS, KidBioSEP, and OFSEP study groups. Cobo-Calvo A, et al. Among authors: collongues n. Ann Neurol. 2021 Jan;89(1):30-41. doi: 10.1002/ana.25909. Epub 2020 Oct 15. Ann Neurol. 2021. PMID: 32959427
Ocrelizumab for the treatment of multiple sclerosis.
Bigaut K, De Seze J, Collongues N. Bigaut K, et al. Among authors: collongues n. Expert Rev Neurother. 2019 Feb;19(2):97-108. doi: 10.1080/14737175.2019.1561284. Epub 2018 Dec 28. Expert Rev Neurother. 2019. PMID: 30570368 Review.
A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis.
Collongues N, Becker G, Jolivel V, Ayme-Dietrich E, de Seze J, Binamé F, Patte-Mensah C, Monassier L, Mensah-Nyagan AG. Collongues N, et al. Neurol Ther. 2022 Sep;11(3):981-1042. doi: 10.1007/s40120-022-00363-7. Epub 2022 May 24. Neurol Ther. 2022. PMID: 35610531 Free PMC article. Review.
MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N, Deschamps R, Cobo Calvo A, Maillart E, Zephir H, Ciron J, Papeix C, Durand-Dubief F, Ruet A, Ayrignac X, Cohen M, Deiva K, Laplaud D, Bourre B, Audoin B, Collongues N, Vukusic S, Cotton F, Marignier R; NOMADMUS study group. Shor N, et al. Among authors: collongues n. Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):39-50. doi: 10.1016/j.neurol.2020.06.016. Epub 2020 Oct 10. Rev Neurol (Paris). 2021. PMID: 33046261 Review.
123 results